ArticleWorld journal of methodology2026
Serum procalcitonin as a predictor of severity of pneumonia in under-five children: A prospective observational study.
Article in World journal of methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite recent advancements in healthcare facilities, the early identification and assessment of pneumonia severity remain major challenges that affect clinical outcomes. These challenges emphasise the necessity for reliable biomarkers that can predict disease severity promptly and precisely. Unlike other markers like C-reactive protein or white blood cell count, procalcitonin (PCT) levels specifically increase in bacterial infections, which are a common cause of severe pneumonia in children.
aimTo evaluate the predictive value of serum PCT in assessing pneumonia severity and clinical outcomes in under-five children.
methodsThis prospective observational study was conducted in a tertiary care teaching hospital in Eastern India from August 2022 to July 2024. Children aged 2 to 59 months admitted with pneumonia underwent serum PCT estimation on day 1 and day 5 of admission. The pneumonia severity was classified as follows: (1) Very severe (intubation, shock, or death); (2) Severe (intensive care admission without very severe features and/or high-flow nasal canula); (3) Moderate (hospitalization without very severe or severe features); and (4) Mild (discharge). Correlation analysis and receiver operating characteristic (ROC) curve analysis were performed to assess the predictive utility of PCT.
resultsTwo hundred children were included. Majority were < 6 months of age, and male (64%). Children in the viral pneumonia group were significantly younger. The pneumonia severity was as follows: (1) Very severe (18%); (2) Severe (24.5%); and (3) Moderate (57.5%). Eighteen (9%) children died. On day 1, the mean ± SD level of serum PCT level for different pneumonia severity was as follows: (1) Moderate (0.47 ± 0.42); (2) Severe (2.04 ± 1.5); and (3) Very severe (4.29 ± 2.37). The differences across the groups were statistically significant (
conclusionThe present study found that serum PCT can predict pneumonia severity including mortality in under-five children. The PCT elevation was significantly higher in bacterial pneumonia compared to viral and atypical pneumonia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.